| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Oncology, University Hospital, N-7006 Trondheim [L. J. V.]; The Norwegian Cancer Registry Montebello, N-0310 Oslo 3 [L. J. V.]; and Central Laboratory, Ullevaal Hospital, N-0407 Oslo 4 [O. P. F.], Norway
The association between total serum cholesterol and triglycerides and the incidence rate of breast cancer has been examined in 242 incident cases of breast cancer that developed among 24,329 Norwegian women during 1114 years of follow-up. At the time of lipid measurement they were between 35 and 51 years of age.
There was an inverse relation between serum cholesterol and risk of breast cancer which was confined to women diagnosed before the age of 51. The incidence rate ratio was 0.53 (95% confidence limits, 0.32 and 0.88) for women in the highest quartile of serum cholesterol (mean = 8.52 mM = 329 mg/100 ml) compared to women in the lowest quartile (mean = 5.28 mM = 204 mg/100 ml), and the relation displayed a negative trend over quartiles of cholesterol (x2 for trend = 3.94, P = 0.05). No association with cholesterol was found among cases diagnosed during the initial 2 years of follow-up, whereas a strong inverse relation was observed among cases that were diagnosed during the following 4 years (x2 trend = 12.6, P < 0.001).
For serum triglycerides there was an overall negative, but not statistically significant, association with breast cancer incidence, which was weakened after further adjustment for body mass index and serum cholesterol. The lack of information on reproductive factors associated with breast cancer risk is a limitation of this study, since potential confounding with the results cannot be excluded.
We conclude that there is an inverse relation between serum cholesterol and breast cancer risk among women diagnosed before the age of 51 years. The findings indicate that the negative association cannot easily be attributed to a preclinical effect of the cancer.
1 This research is based on data made available by The National Health Screening Service and The Cancer Registry of Norway.
2 Research fellow of The Norwegian Cancer Society. To whom requests for reprints should be addressed, at Department of Oncology, University Hospital, N-7006 Trondheim, Norway.
Received 8/31/89.
Revised 12/21/89.
This article has been cited by other articles:
![]() |
X. Yang, W.-Y. So, R. C W Ma, G. T C Ko, A. P S Kong, Q. Wang, C. S Cockram, C.-C. Chow, J. C N Chan, and P. C Y Tong Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes Endocr. Relat. Cancer, June 1, 2008; 15(2): 597 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xue and K. B Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Eliassen, G. A. Colditz, B. Rosner, W. C. Willett, and S. E. Hankinson Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer Arch Intern Med, October 24, 2005; 165(19): 2264 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ward, P. Schulte, B. Grajewski, A. Andersen, D. G. Patterson Jr., W. Turner, E. Jellum, J. A. Deddens, J. Friedland, N. Roeleveld, et al. Serum Organochlorine Levels and Breast Cancer: A Nested Case-Control Study of Norwegian Women Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1357 - 1367. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |